Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL VACCINE ADJUVANT AND USE THEREOF IN NOVEL CORONAVIRUS VACCINES AND OTHER VACCINES
Document Type and Number:
WIPO Patent Application WO/2022/007905
Kind Code:
A1
Abstract:
The present invention relates to the field of biomedicine, and in particular to a novel vaccine adjuvant and the use thereof in novel coronavirus disease vaccines and other vaccines. A chemically modified cyclic dinucleotide, i.e. an SF compound, can be used as a vaccine adjuvant to be combined with the novel coronavirus disease vaccines.

Inventors:
LI YANMEI (CN)
WU JUNJUN (CN)
CHEN YONGXIANG (CN)
Application Number:
PCT/CN2021/105297
Publication Date:
January 13, 2022
Filing Date:
July 08, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV TSINGHUA (CN)
International Classes:
A61K39/215; A61K39/39; A61P11/00; A61P31/14; A61P37/04
Domestic Patent References:
WO2019147509A12019-08-01
Foreign References:
CN111592570A2020-08-28
CN111956797A2020-11-20
CN106540253A2017-03-29
CN106540254A2017-03-29
CA2895175A12014-06-26
Other References:
WANG JI, LI PEIYU, YU YANG, FU YUHONG, JIANG HONGYE, LU MIN, SUN ZHIPING, JIANG SHIBO, LU LU, WU MEI X.: "Pulmonary surfactant–biomimetic nanoparticles potentiate heterosubtypic influenza immunity", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, vol. 367, no. 6480, 21 February 2020 (2020-02-21), US , XP055886569, ISSN: 0036-8075, DOI: 10.1126/science.aau0810
WU JUNJUN, LANG ZHAO, HONG-GUO HU, WEN-HAO LI, YAN-MEI LI : "Agonists and inhibitors of the STING pathway: Potential agents for immunotherapy", MED RES REV, vol. 40, 2 December 2019 (2019-12-02), pages 1117 - 1141, XP055886574, DOI: 10.1002/med.21649
Attorney, Agent or Firm:
TSINGYIHUA INTELLECTUAL PROPERTY LLC (CN)
Download PDF: